Alkaloid AD Skopje (XMAE:ALK) Research & Development: MKD0 Mil (TTM As of Mar. 2026)


XMAE:ALK Alkaloid AD Skopje XMAE:ALK
88 GF Score
Price MKD24,300.00
GF Value MKD27,166.15
Valuation Modestly Undervalued
View Full Analysis

What is Alkaloid AD Skopje Research & Development?

Alkaloid AD Skopje XMAE:ALK +0.21% 88 Research & Development is MKD0 Mil as of Mar. 2026. GuruFocus rates XMAE:ALK with a GF Score™ of 88/100 and a GF Value™ of MKD27,166.15 (Modestly Undervalued).

Research & Development is the aggregate amount of research and development expenses during the year. Alkaloid AD Skopje's Research & Development for the three months ended in Mar. 2026 was MKD0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MKD0 Mil.

Alkaloid AD Skopje  (XMAE:ALK) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alkaloid AD Skopje Research & Development Related Terms

Alkaloid AD Skopje Research & Development Historical Data

* Premium members only.

The historical data trend for Alkaloid AD Skopje's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkaloid AD Skopje Research & Development Chart

Alkaloid AD Skopje Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.66 163.07 189.15 227.85 0.00

Alkaloid AD Skopje Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XMAE:ALK
88GF Score
Alkaloid AD Skopje XMAE:ALK
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkaloid AD Skopje Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MKD0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MKD0 Mil mean?
Alkaloid AD Skopje (XMAE:ALK) has a Research & Development of MKD0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Alkaloid AD Skopje and its competitors.
Is Alkaloid AD Skopje's Research & Development too high?
Alkaloid AD Skopje's current Research & Development is MKD0 Mil. Overall, Alkaloid AD Skopje has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Research & Development compare to ZTS and UTHR?
Alkaloid AD Skopje's Research & Development of MKD0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alkaloid AD Skopje and its competitors. Alkaloid AD Skopje's current Research & Development is MKD0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,300.00 — trading 10.6% below its estimated fair value. The current Research & Development is MKD0 Mil. Alkaloid AD Skopje's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Research & Development is MKD0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD24,300.00 is trading 10.6% below its estimated GF Value™ of MKD27,166.15. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Research & Development: MKD0 Mil
  • GF Value™: MKD27,166.15 vs. price of MKD24,300.00 (10.6% below fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
88GF Score

Get the complete analysis for XMAE:ALK

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD24,300.00
Price
MKD27,166.15
GF Value